CTNNBL1 and neoplasm: All these studies have converged on the notion that the anti-tumor potential of HP-NAP relies on the activation and shaping of the adaptive immune response, but the possibility that HP-NAP might counteract tumor growth due to the modulation of mononuclear cells, regardless of the participation of the adaptive immunity, remained unexplored.